Concord Medical Services Holdings Limited (NYSE:CCM) Sees Large Increase in Short Interest

Concord Medical Services Holdings Limited (NYSE:CCM) was the recipient of a large growth in short interest in August. As of August 14th, there was short interest totaling 7,578 shares, a growth of 63.3% from the July 30th total of 4,641 shares. Based on an average daily volume of 117,289 shares, the short-interest ratio is currently 0.1 days. Approximately 0.3% of the shares of the stock are sold short.

Concord Medical Services Stock Performance

Shares of NYSE:CCM opened at $4.64 on Wednesday. The company has a current ratio of 0.48, a quick ratio of 0.46 and a debt-to-equity ratio of 1.33. The business’s fifty day moving average price is $4.62 and its two-hundred day moving average price is $4.35. Concord Medical Services has a one year low of $3.18 and a one year high of $6.98.

Wall Street Analyst Weigh In

A number of analysts have commented on CCM shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Concord Medical Services in a research report on Friday, August 21st. Wall Street Zen upgraded Concord Medical Services to a “hold” rating in a research report on Saturday, August 15th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Concord Medical Services presently has a consensus rating of “Sell”.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.